These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 28683005)
1. The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible. Girda E; Huang EC; Leiserowitz GS; Smith LH Int J Gynecol Cancer; 2017 Oct; 27(8):1701-1707. PubMed ID: 28683005 [TBL] [Abstract][Full Text] [Related]
2. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors. Maru Y; Tanaka N; Itami M; Hippo Y Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504 [TBL] [Abstract][Full Text] [Related]
3. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues. Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451 [TBL] [Abstract][Full Text] [Related]
4. In vitro drug testing using patient-derived ovarian cancer organoids. Chen LY; Chou YT; Liew PL; Chu LH; Wen KC; Lin SF; Weng YC; Wang HC; Su PH; Lai HC J Ovarian Res; 2024 Oct; 17(1):194. PubMed ID: 39358778 [TBL] [Abstract][Full Text] [Related]
5. Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma. Chen H; Gotimer K; De Souza C; Tepper CG; Karnezis AN; Leiserowitz GS; Chien J; Smith LH Gynecol Oncol; 2020 Jun; 157(3):783-792. PubMed ID: 32253045 [TBL] [Abstract][Full Text] [Related]
6. Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer. Collins A; Miles GJ; Wood J; MacFarlane M; Pritchard C; Moss E Gynecol Oncol; 2020 Jan; 156(1):251-259. PubMed ID: 31767187 [TBL] [Abstract][Full Text] [Related]
7. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping. Burkhart RA; Baker LA; Tiriac H Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724 [TBL] [Abstract][Full Text] [Related]
8. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients. Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues. Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168 [TBL] [Abstract][Full Text] [Related]
10. PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy. Bian X; Gao J; Luo F; Rui C; Zheng T; Wang D; Wang Y; Roberts TM; Liu P; Zhao JJ; Cheng H Oncogene; 2018 Jan; 37(3):341-351. PubMed ID: 28945226 [TBL] [Abstract][Full Text] [Related]
11. The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo. Schrauwen S; Coenegrachts L; Cattaneo A; Hermans E; Lambrechts D; Amant F Gynecol Oncol; 2015 Aug; 138(2):378-82. PubMed ID: 26050920 [TBL] [Abstract][Full Text] [Related]
12. Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing. Bi J; Newtson AM; Zhang Y; Devor EJ; Samuelson MI; Thiel KW; Leslie KK Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200645 [TBL] [Abstract][Full Text] [Related]
13. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing. Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073 [TBL] [Abstract][Full Text] [Related]
14. Drug Sensitivity Assays of Human Cancer Organoid Cultures. Francies HE; Barthorpe A; McLaren-Douglas A; Barendt WJ; Garnett MJ Methods Mol Biol; 2019; 1576():339-351. PubMed ID: 27628132 [TBL] [Abstract][Full Text] [Related]
15. On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study. Sailer V; Pauli C; Merzier EC; Mosquera JM; Beltran H; Rubin MA; Rao RA Anticancer Res; 2017 Apr; 37(4):1569-1573. PubMed ID: 28373416 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells. Byron SA; Loch DC; Pollock PM Int J Gynecol Cancer; 2012 Nov; 22(9):1517-26. PubMed ID: 23060048 [TBL] [Abstract][Full Text] [Related]
17. Hydrogel-based colorectal cancer organoid co-culture models. Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439 [TBL] [Abstract][Full Text] [Related]
18. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial. Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306 [TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer. Maru Y; Kohno M; Suzuka K; Odaka A; Masuda M; Araki A; Itami M; Tanaka N; Hippo Y Hum Cell; 2024 May; 37(3):840-853. PubMed ID: 38546950 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids. de Kort WWB; Millen R; Driehuis E; Devriese LA; van Es RJJ; Willems SM Head Neck Pathol; 2024 Jun; 18(1):59. PubMed ID: 38940869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]